Medidata alternatives for teams priced out of enterprise pharma software
Most research isn't a top-20 pharma Phase III trial, so most research doesn't need Medidata pricing or a six-month implementation. WeGuide gives academic, CRO, and mid-market teams a regulatory-grade platform with eCOA, eConsent, wearables, and a branded participant app, typically live within six weeks.
No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.
.png)
Used by leading research and medical institutes.
%201.avif)
Why research teams look for a Medidata alternative
The typical Medidata buyer conversation sounds like this: a mid-market sponsor or CRO sits down with a Medidata sales team, describes their study, and gets a quote with a six-figure minimum and a four-to-six month implementation runway. For large, complex pharma portfolios, those numbers are reasonable. For everyone else, they're a wall.
Academic medical centres, mid market CROs, investigator led studies, patient registries, and digital health programmes all have the same problem in different forms: Medidata's strengths are real, but the price point and implementation complexity assume an enterprise programme team and an enterprise budget. When those aren't available, teams start looking for alternatives that cover most of the same ground with a faster, lighter, and more accessible delivery model.
The Medidata "alternatives" conversation also splits in two. Some teams are looking for a Medidata Rave alternative (they need EDC and eCRF). Others are looking for a Medidata CTMS alternative (they need trial management, site management, and financial tracking). We cover both below.
.png)
Key differences between WeGuide and Medidata
For teams that don't need Rave's full eCRF depth but do need fast deployment, patient engagement, and a simpler cost story, here's what changes when you move to WeGuide.
.png)
Deploy in weeks, not months
.png)
Accessible pricing for mid market research
.png)
No code programme builder
Full comparison: WeGuide vs Medidata
.png)
Top alternatives to Medidata in 2026
Here's the shortlist of platforms most teams evaluate when they're moving on from Medidata, or when Medidata's pricing rules it out. Each one has a different sweet spot.
.png){kind=small}
.png){kind=small}
All-in-one platform
WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.
.png){kind=icon}
eConsent
.png)
.png){kind=icon}
Screening
.svg)
.svg)
.png){kind=icon}
Data collection
.svg)
.png){kind=icon}
Telehealth
.png)
.png)
.png)
%20(1)%20(1)%20(1).png)
%20(1).png)
.png)
.png)
Continuous engagement, not once-off surveys
Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →
Push notifications and reminders
Study companion
Educational content and gamification
Mobile multimodal collection
Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.
Forms
.svg){kind=icon}
Video
.svg){kind=icon}
Pathology
.svg){kind=icon}
Sensors
.png)
%20(1).png)
.png)
%20(1).png)
.png)
%20(1).png)
.png)
Whitelabel: your study, your brand
WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.
.svg){kind=icon}
Your brand end-to-end
.svg){kind=icon}
App store distribution
.svg){kind=icon}
Multilingual out of the box.
Where WeGuide goes further
For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.
Deploy in weeks, not months
Accessible pricing for mid-market research
No-code programme builder
.svg)
Whitelabel mobile apps under your brand
.svg)
Native Garmin, Apple Health, and Google Fit
.png)
Built-in patient registry capability
Use cases beyond pharma trials
.svg)
Medidata CTMS vs WeGuide
Built for regulated research
Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.
.png){kind=small}
TGA Certified
.png){kind=small}
ISO 27001
.png){kind=small}
Data Hosted in Australia
.png){kind=small}
GDPR Compliant
Biometric Security
.png){kind=small}
256-bit AES Encryption
Faster
Your own platform ready in weeks and changes are made in minutes
Adherence Rates
High patient engagement and better quality data
Cost Saving
Reduce financial and technology risk when creating a secure health app
Patients Impacted
With our ease of use and roll out, our apps have engaged 200k+ users
Where Medidata excels
Market-leading EDC with Rave. Medidata Rave has been the category-defining EDC for two decades. Its eCRF designer, edit-check engine, query management, and data validation have been refined through tens of thousands of studies. For complex late-stage pharma trials, this is still the benchmark.
Enterprise-grade CTMS, RTSM, eCOA, safety, and CDB. Medidata has built out a comprehensive suite that covers most of the clinical trial technology stack. Acorn for safety, Patient Cloud for eCOA, Rave RTSM for randomisation, and the Medidata Clinical Data Studio for analytics and CDB. For teams that want one vendor across the whole stack, this is a real strength.
Part of Dassault Systèmes. The parent company brings R&D investment, enterprise support, and integration with the Dassault portfolio. That matters for some enterprise sponsors.
FDA 21 CFR Part 11 across the stack. Regulatory-grade compliance at enterprise scale, with a long track record of FDA submissions accepting Medidata-sourced data.
Strong in complex, late-stage, global Phase II to IV pharma trials. This is Medidata's home turf, and it's genuinely hard to match at that scale.
If your study is a top-20 pharma late-stage multi-site trial, Medidata is a defensible choice. We'd rather tell you that honestly than pretend WeGuide replaces it in every scenario.
run WeGuide alongside Medidata
If your enterprise portfolio already runs on Medidata Rave for complex late-stage trials, you don't have to rip that out to use WeGuide for your mid-market or engagement-heavy studies. Our Integration Engine connects to Medidata through its APIs, so you can keep Rave for the protocols it suits and run WeGuide for the ones that need faster deployment, patient engagement, or lower cost. Many of the teams we work with run hybrid architectures.
How the switch works
For teams that are ready to move beyond Medidata for specific studies or run WeGuide alongside it, here's how onboarding typically plays out.
Discovery Call
A 30-minute conversation with one of our research delivery team. We look at your protocol, your current Medidata setup, and what's actually blocking you. No sales pitch.
Study Configuration
Our team works alongside yours to configure the study in WeGuide. If you're keeping Medidata for eCRF data, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.
.svg)
Participant Onboarding
The whitelabel app goes live. Your research coordinators invite participants, who download the app under your organisation's brand. Consent flows, engagement templates, and eCOA instruments are ready.
Ongoing Support
You get a named research delivery contact, not a ticketing queue. We stay involved for the life of the study.
.png)
.png)
.png)
.png)
Case studies: research teams that moved faster than enterprise pharma software allows
BRACE Trial (Murdoch Children's Research Institute)
Murdoch Children's Research Institute. A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. Launched across five countries with 6,000+ participants in six weeks during the pandemic. Adherence exceeded 90%. A Medidata implementation wouldn't have finished study configuration in that window.
GenV (Generation Victoria)
A population health study tracking more than 100,000 Victorian families from birth. Longitudinal registry work at this scale isn't in Medidata's product scope, and the whitelabel family-facing app is the reason retention has held across multiple years.
INHERIT
An employee wellbeing deployment across a global workforce, using WeGuide's platform for participant reported outcomes, engagement content, and population health analytics. The kind of programme that sits entirely outside enterprise pharma software.
%201.avif)
Questions
Straight answers on how WeGuide compares to Medidata, what migration looks like, and when Medidata is the right call.
Contact usIs WeGuide a full replacement for Medidata Rave EDC?
Honestly, for large, complex Phase II to IV pharma trials with hundreds of sites and decades of established eCRF libraries, Rave remains the gold standard and we won't pretend otherwise. WeGuide is the right choice when you're a mid-market sponsor, academic institution, investigator-led study, or CRO that doesn't need Rave's full eCRF depth and doesn't want its pricing and implementation timelines. For teams that need both, we often recommend running WeGuide alongside Rave through our Integration Engine rather than replacing it.
Does WeGuide replace Medidata CTMS?
For mid market and academic studies, yes. WeGuide handles participant management, study configuration, analytics, and operational oversight for the kinds of studies that don't need enterprise multi-programme CTMS features. For large pharma portfolios running hundreds of sites across multiple programmes, Medidata CTMS or Veeva Vault CTMS are better suited to that scale.
How does Medidata pricing compare to WeGuide?
Medidata is enterprise custom quoted, typically with six-figure minimums for a single study and longer for multi programme portfolios. Pricing is also often split across Rave, Patient Cloud, CTMS, Sensor Cloud, and other modules, so the total stack cost can climb quickly. WeGuide is project based and scales to your study's complexity, with every module included in the core licence. For mid market sponsors and academic research, WeGuide is typically significantly less expensive, and the implementation cost is lower because you don't need a dedicated programme team.
Can we migrate data from Medidata Rave to WeGuide?
Yes, through our Integration Engine and data import workflows. Rave integration is supported via the Medidata APIs. Most teams don't do a hard cutover. They run the two platforms side by side until they're confident, then gradually consolidate for new studies while keeping existing Rave studies in place.
Does WeGuide have an eCOA module like Medidata Patient Cloud?
Yes. WeGuide's eCOA is integrated into the Form Builder with a library of 200+ validated instruments, and it runs inside the same whitelabel app participants use for the rest of the study. The difference is that Medidata Patient Cloud is a separate module with a separate Medidata-branded participant interface, while WeGuide's eCOA is part of a single integrated participant experience.
How quickly can we deploy?
The BRACE Trial launched in six weeks across five countries with 6,000+ participants. That's our benchmark for a complex multi-site study with rigorous compliance requirements. Simpler studies can launch in two to three weeks. The reason we can move this fast is that our no code programme builder lets research teams configure studies directly without waiting for an enterprise implementation team.
Compare WeGuide to other clinical trial platforms
Eleven more honest platform comparisons, from academic EDC to enterprise pharma.
.png){kind=small}
Veeva Vault Clinical
Life sciences cloud
Thread Research
Virtual CRO + software
Clario
eCOA specialist
Oracle Clinical
Clinical One & InForm
.png){kind=small}
OpenClinica
Open-source EDC
.png){kind=small}
Medable
DCT for top-50 pharma
.png){kind=small}
IQVIA
Full-service CRO
Florence Healthcare
Site-side workflow
Science 37
Open-source EDC
obviohealth
Virtual site service
Medidata Rave
Enterprise pharma stack
REDCap
Data Collection
Never miss an update
Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.
By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.
Certified and Compliant by Leading Standards
